BioSpace News Archive

Business

Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022

Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its first quarter 2022 financial results will be released after the close of the United States financial markets on Thursday, May 5th, 2022.

April 29, 2022
·
1 min read
Business

Pixium Vision announces the availability of its audited financial statements for the financial year 2021

Pixium Vision SA announces that its audited financial statements for the year 2021 have been made available on the company’s website.

April 29, 2022
·
6 min read
Policy

Grifols 2021 Annual Report on Form 20-F filed with the SEC on April 29, 2022

Grifols, S.A. announced that it has filed its 2021 Annual Report on Form 20-F with the United States Securities and Exchange Commission on April 29, 2022.

April 29, 2022
·
2 min read
Cerebral Thrombectomy Systems Market Size, Developments Status, Trends and Key Players Analysis, Forecast 2027

The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

April 29, 2022
·
6 min read
Antibody Production Market Size 2022-2030- Increased Demand For Therapeutic Antibodies Is Driving Antibody Production Market Growth

Rising prevalence of infectious diseases, increased R&D spending, and increased use of antibiotics in the production of bacterial and viral vaccines are expected to drive market revenue growth.

April 29, 2022
·
8 min read
Biotech Beach

Zosano Pharma Provides Corporate Update

Zosano Pharma Corporation, a clinical-stage biopharmaceutical company, provided a corporate update.

April 29, 2022
·
3 min read
Rapid Test Kit Market Size 2022-2030 - Integration Of Artificial Intelligence (AI) In Rapid Test Kits

Increased adoption of convenient home testing kits with fast and accurate results is driving rapid test kits market revenue growth.

April 29, 2022
·
8 min read
Pharm Country

Aptorum Group Limited Reports 2021 Fiscal Year End Financial Results and Provides Business Update

Aptorum Group Limited announced financial results for the fiscal year ended December 31, 2021, and provided an update on clinical and corporate developments.

April 29, 2022
·
12 min read
Pharm Country

PTC Therapeutics to Participate at Upcoming Investor Conferences - Apr 29, 2022

PTC Therapeutics, Inc. announced that management will present a company overview at the following conferences.

April 29, 2022
·
1 min read
BioMidwest

First Wave BioPharma Chairman and CEO Issues Letter to Shareholders - Apr 29, 2022

First Wave BioPharma, Inc. announced that James Sapirstein, Chairman, President and CEO First Wave BioPharma, has issued a Letter to Shareholders to provide an update on recent events and an outlook for the Company’s clinical programs in 2022.

April 29, 2022
·
7 min read